Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|July 24, 2010
Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 studyLucio Crinò, Eric Dansin, Pilar Garrido, et al.
JTO Clinical and Research Reports|January 31, 2024
The Perceived Value of Liquid Biopsy: Results From a Canadian Validation Study of Circulating Tumor DNA <i>T790M</i> Testing-Patient's Willingness-to-Pay: A Brief ReportKaitlin H Chen, Tristan A Barnes, Janessa Laskin, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2025
Mitigation of decline with virtual exercise with lung cancer (MoVE with lung cancer) - A promising approach to enhance physiological strength, improve body composition, and build upon current evidenceYing Wang, Rafael A Fujita, Natalie Fujisawa, et al.
American Journal of Surgery|March 10, 2012
Beta-catenin expression is prognostic of improved non-small cell lung cancer survivalConnie G Chiu, Simon K Chan, Z Amy Fang, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 ExpressionMarie-Hélène Denault, Jamie Feng, Shelley Kuang, et al.
Scientific Reports|May 6, 2025
Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their clinical implicationsKathleen Wee, Kevin C Yang, David F Schaeffer, et al.
Lancet Regional Health. Americas|November 28, 2024
Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based studyEmanuel Krebs, Deirdre Weymann, Cheryl Ho, et al.
Translational Lung Cancer Research|September 21, 2020
EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomesAlexandra Pender, Curtis Hughesman, Elaine Law, et al.
Cold Spring Harbor Molecular Case Studies|April 28, 2022
Whole-genome and transcriptome analysis of advanced adrenocortical cancer highlights multiple alterations affecting epigenome and DNA repair pathwaysJean-Michel Lavoie, Veronika Csizmok, Laura M Williamson, et al.
Genes, Chromosomes & Cancer|September 20, 2024
Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic RhabdomyosarcomaVeronika Csizmok, Cameron J Grisdale, Laura M Williamson, et al.
Pageof 12